Medtronic (MDT) Free Cash Flow Growth (3y) (2017 - 2026)

Medtronic (MDT) Free Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.75 Bn 176.46 Bn 6.27 Bn 6.28%
2 Stryker 129.05 Bn 126.17 Bn 3.81 Bn 9.63%
3 Medtronic 108.57 Bn 99.35 Bn 6.41 Bn 0.05%
4 Boston Scientific 68.61 Bn 67.16 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 48.41 Bn 44.74 Bn 1.29 Bn -27.72%
6 Dexcom 28.35 Bn 27.23 Bn 750.30 Mn 77.20%
7 GE HealthCare Technologies 28.12 Bn 25.83 Bn 1.98 Bn -29.89%
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 24.26 Bn 21.14 Bn 2.07 Bn -0.27%
10 Steris 21.43 Bn 20.99 Bn 697.10 Mn 19.32%

Historic Data

Download Data
DateValue
Apr 24, 2026 0.05%
Jan 23, 2026 22.80%
Oct 24, 2025 -8.62%
Jul 25, 2025 -3.85%
Apr 25, 2025 7.45%
Jan 24, 2025 3.36%
Oct 25, 2024 -28.22%
Jul 26, 2024 -20.11%
Apr 26, 2024 19.78%
Jan 26, 2024 2.21%
Oct 27, 2023 -49.79%
Jul 28, 2023 124.43%
Apr 28, 2023 23.18%
Jan 27, 2023 -16.25%
Oct 28, 2022 -27.69%
Jul 29, 2022 -18.40%
Apr 29, 2022 -1.62%
Jan 28, 2022 2.68%
Oct 29, 2021 16.11%
Jul 30, 2021 -13.48%